The Coca-Cola Company (NYSE: KO) announced today a $2.4 billion cash offer for China Huiyuan Juice Group, Ltd. (HK: 1886), valuing the company at nearly three times its previous day closing price, or approximately 43 times its 2008 forecasted earnings.

Through RISC China, Revere’s industry classification system covering all 2,600 companies trading on the Shanghai, Shenzhen, and Hong Kong exchanges, users of Revere are able to identify the complete list of publicly-traded Chinese soft drink and juice companies that could become the next acquisition target or experience upward revaluation driven by the Coke-Huiyan offer.

The complete list includes 31 companies, of which 7 are focused companies that derive a majority of their revenue from the soft drink and juice market. Furthermore, 12 of the 31 are listed on the Hong Kong Stock Exchange, 6 on the Shenzhen Stock Exchange, and 13 on the Shanghai Stock Exchange. Examples of these companies include China Haisheng Juice Holdings Co., Ltd. (HK: 0359), Yantai North Andre Juice Co., Ltd. (HK: 8259), and SDIC Zhonglu Fruit Juice Co., Ltd. (Shanghai: 600962). 

For additional names and tickers of these 31 companies, please contact our Research, Sales and Customer Support teams.

Sincerely,

Revere Research Team

CONTACTS
Research: research@reveredata.com
Sales: sales@reveredata.com
Customer Support: support@reveredata.com

DISCLAIMER
Revere Data, LLC is an independent provider of investment research and information and does not offer investment advice. Any mention of a specific company is not a recommendation to buy or sell a security of that company. Revere Data, LLC permits its analysts and members of their immediate families to invest and trade in the securities of the companies in the industry and industries covered by Revere Data, LLC. Though Revere Data, LLC is not required to be a registered investment advisor under the Investment Advisor Act of 1940 or as an investment advisor with any state, Revere Data, LLC voluntarily applies relevant and pertinent rules and procedures adopted by the NYSE and NASD as may be approved from time to time by the SEC relating to the issues of analyst independence and objectivity.